Moisture Testing and Its Impact on ODF & Tablet Stability
Share
Introduction
Throughout the lifecycle of solid dosage forms—during production, transportation, and storage—moisture content plays a critical role in determining product stability. Excess moisture may cause softening, deformation, or microbial risks, while insufficient moisture can lead to brittleness, compromising appearance and dosage uniformity. Moisture testing is therefore essential not only for in-process quality control, but also for long-term stability assurance.
1. The Link Between Moisture and Storage Stability
Interested in pharmaceutical testing instruments?
Contact Huanghai for specifications, technical consultation, and quotation. Request a Quote →
- Sensitivity to Temperature and Humidity: ODFs and tablets are prone to moisture uptake and degradation in high-humidity environments.
- Packaging Compatibility: Moisture barrier performance varies between packaging types such as foil, bottles, or pouches—making moisture testing vital for validation.
- Shelf-Life Evaluation: High or fluctuating moisture levels can directly shorten product shelf life and impact regulatory acceptance.
2. Common Challenges in the Industry
- Single-Point Testing: Many manufacturers only test moisture at the time of release, ignoring dynamic changes during storage.
- Packaging Neglect: Moisture validation often focuses on the final product, omitting packaging and simulated storage condition testing.
- Time-Consuming Methods: Traditional oven-drying techniques are inefficient and unsuited for fast-paced batch environments.
3. Industry Trends
- Rapid Moisture Analysis: Electronic moisture analyzers are increasingly replacing traditional oven methods for higher efficiency.
- Expanded Stability Studies: Companies are aligning with ICH guidelines to integrate moisture testing into accelerated and long-term studies.
- End-to-End Quality Control: Moisture analysis is now being extended to raw materials and intermediates, not just final products.
4. HUANGHAI’s Moisture Testing Solutions
- Our HY-310 Electronic Moisture Analyzer supports testing of ODF films, tablets, and powders.
- Offers fast detection, easy operation, and suitability for large-scale quality control and stability trials.
- Delivers high accuracy in compliance with pharmacopoeial standards, minimizing risks during registration and export.
👉 Recommended Product:
HY-310 Electronic Moisture Analyzer
Conclusion
Moisture testing is a small but vital step in ensuring the long-term quality of solid dosage forms. By adopting fast and reliable moisture testing technologies, pharmaceutical and supplement manufacturers can effectively predict shelf-life, mitigate regulatory risks, and enhance market competitiveness.
Frequently Asked Questions
Q: What is the difference between an ODF film and a transdermal patch?
A: Oral Dissolving Films (ODF) are placed on or under the tongue and dissolve within seconds to minutes, delivering APIs directly through the oral mucosa or via swallowing. Transdermal patches adhere to the skin and deliver APIs through the dermal layers into systemic circulation over hours to days. Despite different delivery routes, both are manufactured using similar solvent-cast film coating processes. Huanghai's MJ150 ODF machine supports both applications on a single platform with approximately 2 working days of changeover time.
Q: What production output can I expect from a Huanghai ODF machine?
A: The MJ150 produces 20,000 films/hour at commercial scale. The MJ150-L targets R&D and pilot production at 8,000–10,000 films/hour. For fully integrated lines, pair either machine with the MJ180 automatic cutting and packaging system (11,900 films/hr) or the more affordable EZ320 (9,000 films/hr). A complete MJ150 + MJ180 line can produce over 150 million finished pouches annually on a single-shift basis. Contact us for pricing and configuration details.
Q: What drying technology does Huanghai use for ODF production?
A: Huanghai uses patented gradient hot-air drying (Patent CN201668734U), which applies a smooth progressive temperature drop rather than stepwise oven zones used by competitors. This results in more uniform film thickness, reduced edge curl, and better API distribution across the film web. An optional far-infrared heating module adds 20–30% drying efficiency for solvent-based formulations. This patented drying system is one of the key technical advantages that justifies Huanghai's position as the preferred ODF equipment supplier to Sinopharm, Shanghai Pharma, and Fosun Pharma.
Q: What are the GMP requirements for ODF production equipment?
A: ODF manufacturing equipment must comply with cGMP (21 CFR Parts 210/211) for US market products, and equivalent standards (EU GMP Annex 1, ChGMP) for other markets. Key requirements: material contact surfaces must be 316L stainless steel or equivalent; CIP/SIP capability or documented cleaning validation; data integrity controls meeting ALCOA+ principles (audit trails, access control). Huanghai ODF machines meet these standards—all product contact surfaces use pharmaceutical-grade materials, and the control system includes operator access logs and parameter change records. Request our GMP compliance documentation.
For a full overview of the certifications and compliance standards our equipment meets, see our Certifications & Compliance page.
Q: Can Huanghai machines produce stripe-coated or multi-formula ODF films?
A: Yes. Huanghai holds a patent for multi-formula stripe coating (Patent CN117323228A), enabling two different API formulations to be applied side-by-side in a single coating pass. This eliminates the need for multiple coating/drying cycles when producing combination-drug ODF products. Competitors require manual multi-layer coating with drying intervals between each formula. This capability is particularly valuable for fixed-dose combination products (e.g., dual-API ODFs for cardiovascular or CNS indications) where coating efficiency directly impacts production economics.